Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$7.48 - $10.7 $619,067 - $885,564
-82,763 Reduced 77.26%
24,359 $248,000
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $1.51 Million - $1.99 Million
-209,884 Reduced 66.21%
107,122 $806,000
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $61,671 - $83,876
-7,377 Reduced 2.27%
317,006 $2.81 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $227,640 - $271,450
28,634 Added 9.68%
324,383 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $826,369 - $1.44 Million
120,462 Added 68.72%
295,749 $2.39 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $72,988 - $102,856
9,890 Added 5.98%
175,287 $1.32 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $79,474 - $102,511
-10,060 Reduced 5.73%
165,397 $1.33 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $2.1 Million - $2.56 Million
-251,031 Reduced 58.86%
175,457 $1.71 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $1.43 Million - $1.67 Million
-144,233 Reduced 25.27%
426,488 $4.22 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $3.58 Million - $4.44 Million
-346,578 Reduced 37.78%
570,721 $6.59 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $1.33 Million - $1.7 Million
154,019 Added 20.18%
917,299 $8.85 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $1.62 Million - $2.4 Million
188,940 Added 32.9%
763,280 $6.88 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $3.17 Million - $5.13 Million
390,777 Added 212.88%
574,340 $7.08 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $1.23 Million - $2.47 Million
183,563 New
183,563 $1.65 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.